Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zhanjing Dai"'
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 6, Pp 1757-1772 (2024)
Abstract Introduction Chronic non-infectious uveitis affecting the posterior segment (NIU-PS), which can be recurrent and persistent for numerous years, mainly affects people of working age and significantly increases the risk of visual impairment. T
Externí odkaz:
https://doaj.org/article/590e0dfdd24f4d199c1a6602706ba085
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundIruplinalkib is a second-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) with efficacy in patients with ALK-positive crizotinib-resistant advanced non-small cell lung cancer (NSCLC), which is independently develo
Externí odkaz:
https://doaj.org/article/3df4cdabb1ce4daa87ec7d6feb007bc3
Publikováno v:
Health and Quality of Life Outcomes, Vol 20, Iss 1, Pp 1-9 (2022)
Abstract Background Almost all traditional Chinese medicine (TCM) quality of life measures are non-preference-based measures (non-PBMs), which do not provide utilities for cost-utility analysis in pharmacoeconomic evaluation. Whereas the mapping has
Externí odkaz:
https://doaj.org/article/80959c54a2c945a49013274a9a6b73e2
Publikováno v:
BMJ Open, Vol 12, Iss 4 (2022)
Objectives To determine the effects of biological disease-modifying anti-rheumatic drugs (bDMARDs) on the quality of life (QoL) among patients with psoriatic arthritis (PsA).Design Meta-analysis.Data sources and eligibility criteria PubMed, Web of Sc
Externí odkaz:
https://doaj.org/article/0f467e961d554234871b2cbe5a5024e0
Publikováno v:
PharmacoEconomics. 41:295-306
Publikováno v:
Inflammopharmacology. 30:1063-1077
Background A meta-analysis of randomized controlled trials (RCTs) was conducted to systematically evaluate the effects of berberine on the inflammatory markers of metabolic syndrome (MetS) and related disorders. Method Databases that were searched fr
Publikováno v:
BMJ Open. 12:e058497
ObjectivesTo determine the effects of biological disease-modifying anti-rheumatic drugs (bDMARDs) on the quality of life (QoL) among patients with psoriatic arthritis (PsA).DesignMeta-analysis.Data sources and eligibility criteriaPubMed, Web of Scien